Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1][2] Group 1: Momentum Investing Strategy - Momentum investors typically do not time the market, instead they capitalize on stocks that are already trending upwards [1] - The challenge lies in determining the right entry point, as stocks can lose momentum if their valuations exceed future growth potential [2] Group 2: Investment Opportunities - A safer approach involves investing in bargain stocks that exhibit recent price momentum, identified through the Zacks Momentum Style Score [3] - LATAM (LTM) is highlighted as a strong candidate, showing a four-week price change of 1.8% and a 12-week gain of 2.3% [4][5] - LTM has a high beta of 3.49, indicating it moves 249% more than the market, suggesting significant volatility [5] Group 3: Performance Metrics - LTM has a Momentum Score of A, indicating a favorable time to invest based on momentum [6] - The stock has a Zacks Rank 1 (Strong Buy) due to upward revisions in earnings estimates, which attract more investor interest [7] - LTM is trading at a Price-to-Sales ratio of 0.73, suggesting it is undervalued at 73 cents for each dollar of sales [7] Group 4: Additional Opportunities - Besides LTM, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - The Zacks Premium Screens offer over 45 different strategies tailored to outperform the market [9]

Company Overview - Roche Holding AG (RHHBY) currently holds a Momentum Style Score of B, indicating a favorable position in momentum investing [3] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [4] Price Performance - Over the past week, RHHBY shares increased by 1.59%, while the Zacks Large Cap Pharmaceuticals industry rose by 3.52% [6] - In a longer time frame, RHHBY's monthly price change is 3.56%, outperforming the industry's 1.85% [6] - Over the last quarter, RHHBY shares have increased by 0.59%, and over the past year, they have gained 37.04% [7] - In comparison, the S&P 500 has moved -7.43% over the last quarter and 12.15% over the past year [7] Trading Volume - RHHBY's average 20-day trading volume is 2,416,640 shares, which serves as a price-to-volume baseline for assessing momentum [8] Earnings Outlook - In the past two months, two earnings estimates for RHHBY have moved higher, with no downward revisions, boosting the consensus estimate from $2.83 to $2.93 [10] - For the next fiscal year, three estimates have increased, with no downward revisions during the same period [10] Conclusion - Considering the positive price performance, trading volume, and favorable earnings outlook, RHHBY is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a potential candidate for near-term investment [12]

Group 1: Momentum Investing Overview - Momentum investing contrasts with the traditional "buy low and sell high" strategy, focusing instead on "buying high and selling higher" to capitalize on fast-moving stocks [1] - Identifying the right entry point for trending stocks can be challenging, as they may lose momentum if future growth does not justify their high valuations [1] Group 2: Investment Strategy - A safer investment approach involves targeting bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [2] - The 'Fast-Paced Momentum at a Bargain' screen is effective in spotting fast-moving stocks that remain attractively priced [2] Group 3: Digital Turbine (APPS) Analysis - Digital Turbine (APPS) has shown a four-week price change of 1.4%, indicating growing investor interest [3] - Over the past 12 weeks, APPS stock has gained 18.1%, demonstrating its ability to deliver positive returns over a longer timeframe [4] - APPS has a beta of 2.41, suggesting it moves 141% higher than the market in either direction, indicating fast-paced momentum [4] Group 4: Valuation and Earnings Estimates - APPS has a Momentum Score of A, suggesting it is an opportune time to invest in the stock [5] - The stock has a Zacks Rank 2 (Buy) due to an upward trend in earnings estimate revisions, which typically attracts more investor interest [6] - APPS is trading at a Price-to-Sales ratio of 0.65, indicating it is relatively cheap, as investors pay only 65 cents for each dollar of sales [6] Group 5: Additional Opportunities - Besides APPS, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [7] - The Zacks Premium Screens offer over 45 different strategies tailored to help investors find winning stock picks [8]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Takeda Pharmaceutical Co. (TAK) - Takeda currently holds a Momentum Style Score of B, indicating potential for solid momentum [2] - The company has a Zacks Rank of 1 (Strong Buy), suggesting strong performance expectations [3] Performance Metrics - Over the past week, TAK shares increased by 2.18%, while the Zacks Medical - Drugs industry rose by 6.64% [5] - In a longer timeframe, TAK's monthly price change is 2.55%, outperforming the industry's 0.87% [5] - Over the past quarter, TAK shares have risen by 14.72%, and by 16.82% over the last year, compared to the S&P 500's performance of -7.64% and 10.16% respectively [6] Trading Volume - The average 20-day trading volume for TAK is 2,489,083 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the last two months, one earnings estimate for TAK has increased, while none have decreased, raising the consensus estimate from $1.55 to $1.58 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions [9] Conclusion - TAK is positioned as a 1 (Strong Buy) stock with a Momentum Score of B, making it a noteworthy candidate for near-term investment [11]

Company Overview - Bank of NT Butterfield & Son (NTB) currently holds a Momentum Style Score of A, indicating strong momentum potential [3] - The company has a Zacks Rank of 1 (Strong Buy), which is associated with a historical outperformance in the market [4] Price Performance - NTB shares have increased by 5.07% over the past week, outperforming the Zacks Banks - Foreign industry, which rose by 3.61% during the same period [6] - Over the last quarter, NTB shares have gained 7.09%, and over the past year, they have increased by 19%, while the S&P 500 has seen declines of -7.64% and gains of only 10.16% respectively [7] Trading Volume - The average 20-day trading volume for NTB is 186,561 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for NTB has been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from $4.40 to $4.95 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions, indicating positive earnings momentum [10] Conclusion - Given the strong price performance, positive earnings outlook, and high momentum score, NTB is positioned as a promising investment opportunity [12]

Group 1: Company Overview - Cidara Therapeutics (CDTX) currently has a Momentum Style Score of B, indicating a positive momentum outlook [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Group 2: Performance Metrics - CDTX shares have increased by 10.8% over the past week, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 6.19% [5] - Over the past month, CDTX's price change is 11.63%, compared to the industry's 2.23% [5] - In the last quarter, CDTX shares increased by 5.39%, and over the past year, they have gained 76.29%, while the S&P 500 has moved -7.64% and 10.16% respectively [6] Group 3: Trading Volume - The average 20-day trading volume for CDTX is 162,652 shares, which serves as a bullish indicator when combined with rising stock prices [7] Group 4: Earnings Outlook - In the past two months, one earnings estimate for CDTX has moved higher, while none have moved lower, resulting in an increase in the consensus estimate from -$14.39 to -$7.12 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [9] Group 5: Conclusion - Considering all performance metrics and earnings outlook, CDTX is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a potential candidate for near-term investment [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: CME Group - CME Group currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Price Performance - Over the past week, CME shares increased by 1.44%, while the Zacks Securities and Exchanges industry rose by 2.89% [5] - In a longer timeframe, CME shares have appreciated by 12.3% over the past quarter and 29.92% over the last year, outperforming the S&P 500, which saw declines of -7.64% and gains of 10.16% respectively [6] Trading Volume - CME's average 20-day trading volume is 2,997,252 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the last two months, 10 earnings estimates for CME have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $10.53 to $11.11 [9] - For the next fiscal year, 9 estimates have moved higher, while 1 has been revised downwards [9] Conclusion - Considering the positive price trends, strong earnings outlook, and favorable momentum score, CME Group is identified as a solid momentum pick for investors [11]

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead ...

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Summary: Integra Resources Corp. (ITRG) - ITRG currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] - Over the past week, ITRG shares increased by 2.37%, outperforming the Zacks Mining - Miscellaneous industry, which rose by 1.14% [5] - In the last month, ITRG's price surged by 42.74%, significantly higher than the industry's 1.05% increase [5] - Over the past quarter, ITRG shares rose by 66.98%, and over the last year, they increased by 123.77%, while the S&P 500 experienced declines of -8.61% and a modest gain of 9.87%, respectively [6] - The average 20-day trading volume for ITRG is 1,122,872 shares, indicating strong trading activity [7] Earnings Outlook - In the past two months, four earnings estimates for ITRG have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $0.16 to $0.31 [9] - For the next fiscal year, one estimate has moved upwards, with no downward revisions noted [9] Conclusion - Given the strong momentum indicators and positive earnings outlook, ITRG is positioned as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for investors seeking short-term gains [11]

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...